ANAPTYSBIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ANAPTYSBIO, INC. (ANAB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 668.40 thousand shares for the 6-month period ending 2026-06-30, per its 10-KT filed 2026-09-21.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-09-21
- ANAPTYSBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- ANAPTYSBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 668.40K shares, a 61.71% decline year-over-year.
- ANAPTYSBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- ANAPTYSBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 12.59K shares, a 81.76% decline year-over-year.
- ANAPTYSBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.76M shares, a 27.46% decline from fiscal 2024.
- ANAPTYSBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.42M shares, a 53.47% increase from fiscal 2023.
- ANAPTYSBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.58M shares, a 6.72% decline from fiscal 2022.
- ANAPTYSBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.69M shares, a 53.10% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-KT 6 month − 10-Q 3 month · filed 2026-09-21 | 668.40K shares 10-KT · filed 2026-09-21 | 668.40K shares derived: sum of 3 quarters · filed 2026-09-21 | 680.99K shares derived: sum of 4 quarters · filed 2026-09-21 | |
| 2026-03-31 | 668.40K shares 10-Q · filed 2026-05-12 | 668.40K shares derived: sum of 2 quarters · filed 2026-09-21 | 680.99K shares derived: sum of 3 quarters · filed 2026-09-21 | 680.99K shares derived: sum of 4 quarters · filed 2026-09-21 | |
| 2025-12-31 | 0.00 shares derived: 10-KT 12 month − 10-Q 9 month · filed 2026-09-21 | 12.59K shares derived: sum of 2 quarters · filed 2026-09-21 | 12.59K shares derived: sum of 3 quarters · filed 2026-09-21 | 1.76M shares 10-KT · filed 2026-09-21 | |
| 2025-09-30 | 12.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 12.59K shares derived: sum of 2 quarters · filed 2025-11-04 | 1.76M shares 10-Q · filed 2025-11-04 | 1.95M shares derived: sum of 4 quarters · filed 2025-11-04 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 1.75M shares 10-Q · filed 2025-08-06 | 1.94M shares derived: sum of 3 quarters · filed 2025-08-06 | 2.01M shares derived: sum of 4 quarters · filed 2025-08-06 | |
| 2025-03-31 | 1.75M shares 10-Q · filed 2025-05-05 | 1.94M shares derived: sum of 2 quarters · filed 2025-05-05 | 2.01M shares derived: sum of 3 quarters · filed 2025-05-05 | 2.19M shares derived: sum of 4 quarters · filed 2025-05-05 | |
| 2024-12-31 | 194.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 263.90K shares derived: sum of 2 quarters · filed 2025-02-27 | 448.46K shares derived: sum of 3 quarters · filed 2025-02-27 | 2.42M shares 10-K · filed 2025-02-27 | |
| 2024-09-30 | 69.03K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | 253.59K shares derived: sum of 2 quarters · filed 2024-11-05 | 2.23M shares 10-Q · filed 2024-11-05 | 2.38M shares derived: sum of 4 quarters · filed 2024-11-05 | |
| 2024-06-30 | 184.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | 2.16M shares 10-Q · filed 2024-08-05 | 2.31M shares derived: sum of 3 quarters · filed 2024-08-05 | 2.43M shares derived: sum of 4 quarters · filed 2024-08-05 | |
| 2024-03-31 | 1.98M shares 10-Q · filed 2024-05-09 | 2.13M shares derived: sum of 2 quarters · filed 2024-05-09 | 2.25M shares derived: sum of 3 quarters · filed 2024-05-09 | 2.46M shares derived: sum of 4 quarters · filed 2024-05-09 | |
| 2023-12-31 | 152.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 273.69K shares derived: sum of 2 quarters · filed 2024-03-11 | 487.88K shares derived: sum of 3 quarters · filed 2024-03-11 | 1.58M shares 10-K · filed 2024-03-11 | |
| 2023-09-30 | 121.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 335.38K shares derived: sum of 2 quarters · filed 2023-11-02 | 1.43M shares 10-Q · filed 2023-11-02 | 1.78M shares derived: sum of 4 quarters · filed 2023-11-02 | |
| 2023-06-30 | 214.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 1.31M shares 10-Q · filed 2023-08-07 | 1.66M shares derived: sum of 3 quarters · filed 2023-08-07 | 1.79M shares derived: sum of 4 quarters · filed 2023-08-07 | |
| 2023-03-31 | 1.09M shares 10-Q · filed 2023-05-11 | 1.44M shares derived: sum of 2 quarters · filed 2023-05-11 | 1.57M shares derived: sum of 3 quarters · filed 2023-05-11 | 1.63M shares derived: sum of 4 quarters · filed 2023-05-11 | |
| 2022-12-31 | 353.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 480.16K shares derived: sum of 2 quarters · filed 2023-03-01 | 543.53K shares derived: sum of 3 quarters · filed 2023-03-01 | 1.69M shares 10-K · filed 2023-03-01 | |
| 2022-09-30 | 126.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 190.17K shares derived: sum of 2 quarters · filed 2022-11-08 | 1.34M shares 10-Q · filed 2022-11-08 | 1.39M shares derived: sum of 4 quarters · filed 2022-11-08 | |
| 2022-06-30 | 63.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 1.21M shares 10-Q · filed 2022-08-08 | 1.26M shares derived: sum of 3 quarters · filed 2022-08-08 | 1.28M shares derived: sum of 4 quarters · filed 2022-08-08 | |
| 2022-03-31 | 1.15M shares 10-Q · filed 2022-05-04 | 1.20M shares derived: sum of 2 quarters · filed 2022-05-04 | 1.22M shares derived: sum of 3 quarters · filed 2022-05-04 | 1.24M shares derived: sum of 4 quarters · filed 2022-05-04 | |
| 2021-12-31 | 48.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | 68.47K shares derived: sum of 2 quarters · filed 2022-03-07 | 94.12K shares derived: sum of 3 quarters · filed 2022-03-07 | 1.11M shares 10-K · filed 2022-03-07 | |
| 2021-09-30 | 19.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 45.25K shares derived: sum of 2 quarters · filed 2021-11-04 | 1.06M shares 10-Q · filed 2021-11-04 | 1.14M shares derived: sum of 4 quarters · filed 2021-11-04 | |
| 2021-06-30 | 25.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 1.04M shares 10-Q · filed 2021-08-09 | 1.12M shares derived: sum of 3 quarters · filed 2021-08-09 | 1.43M shares derived: sum of 4 quarters · filed 2021-08-09 | |
| 2021-03-31 | 1.01M shares 10-Q · filed 2021-05-04 | 1.09M shares derived: sum of 2 quarters · filed 2021-05-04 | 1.41M shares derived: sum of 3 quarters · filed 2021-05-04 | 1.44M shares derived: sum of 4 quarters · filed 2021-05-04 | |
| 2020-12-31 | 78.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 397.18K shares derived: sum of 2 quarters · filed 2021-02-25 | 424.27K shares derived: sum of 3 quarters · filed 2021-02-25 | 539.83K shares 10-K · filed 2021-02-25 | |
| 2020-09-30 | 318.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 345.88K shares derived: sum of 2 quarters · filed 2020-11-04 | 461.43K shares 10-Q · filed 2020-11-04 | 1.49M shares derived: sum of 4 quarters · filed 2020-11-04 | |
| 2020-06-30 | 27.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 142.65K shares 10-Q · filed 2020-08-10 | 1.17M shares derived: sum of 3 quarters · filed 2020-08-10 | 1.21M shares derived: sum of 4 quarters · filed 2020-08-10 | |
| 2020-03-31 | 115.55K shares 10-Q · filed 2020-05-06 | 1.14M shares derived: sum of 2 quarters · filed 2020-05-06 | 1.19M shares derived: sum of 3 quarters · filed 2020-05-06 | 1.21M shares derived: sum of 4 quarters · filed 2020-05-06 | |
| 2019-12-31 | 1.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 1.07M shares derived: sum of 2 quarters · filed 2020-03-02 | 1.09M shares derived: sum of 3 quarters · filed 2020-03-02 | 1.61M shares 10-K · filed 2020-03-02 | |
| 2019-09-30 | 45.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 68.57K shares derived: sum of 2 quarters · filed 2019-11-08 | 584.87K shares 10-Q · filed 2019-11-08 | 613.92K shares derived: sum of 4 quarters · filed 2019-11-08 | |
| 2019-06-30 | 23.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 539.40K shares 10-Q · filed 2019-08-08 | 568.45K shares derived: sum of 3 quarters · filed 2019-08-08 | 633.55K shares derived: sum of 4 quarters · filed 2019-08-08 | |
| 2019-03-31 | 516.30K shares 10-Q · filed 2019-05-07 | 545.35K shares derived: sum of 2 quarters · filed 2019-05-07 | 610.45K shares derived: sum of 3 quarters · filed 2019-05-07 | 622.20K shares derived: sum of 4 quarters · filed 2019-05-07 | |
| 2018-12-31 | 29.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | 94.15K shares derived: sum of 2 quarters · filed 2019-02-28 | 105.90K shares derived: sum of 3 quarters · filed 2019-02-28 | 368.61K shares 10-K · filed 2019-02-28 | |
| 2018-09-30 | 65.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 76.85K shares derived: sum of 2 quarters · filed 2018-11-08 | 339.56K shares 10-Q · filed 2018-11-08 | 378.26K shares derived: sum of 4 quarters · filed 2019-02-28 | |
| 2018-06-30 | 11.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 274.46K shares 10-Q · filed 2018-08-07 | 313.16K shares derived: sum of 3 quarters · filed 2019-02-28 | 413.12K shares derived: sum of 4 quarters · filed 2019-02-28 | |
| 2018-03-31 | 262.71K shares 10-Q · filed 2018-05-08 | 301.41K shares derived: sum of 2 quarters · filed 2019-02-28 | 401.37K shares derived: sum of 3 quarters · filed 2019-02-28 | 428.37K shares derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-12-31 | 38.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | 138.66K shares derived: sum of 2 quarters · filed 2019-02-28 | 165.66K shares derived: sum of 3 quarters · filed 2019-02-28 | 1.10M shares 10-K · filed 2019-02-28 | |
| 2017-09-30 | 99.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 126.97K shares derived: sum of 2 quarters · filed 2018-11-08 | 1.06M shares 10-Q · filed 2018-11-08 | 1.11M shares derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | 27.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 961.14K shares 10-Q · filed 2018-08-07 | 964.14K shares 10-Q · filed 2017-08-10 | 1.01M shares derived: sum of 3 quarters · filed 2019-02-28 | 1.26M shares derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | 934.14K shares 10-Q · filed 2018-05-08 | 985.85K shares derived: sum of 2 quarters · filed 2019-02-28 | 1.23M shares derived: sum of 3 quarters · filed 2019-02-28 | 1.26M shares derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | 51.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | 300.06K shares derived: sum of 2 quarters · filed 2019-02-28 | 330.62K shares derived: sum of 3 quarters · filed 2019-02-28 | 330.62K shares 10-K · filed 2019-02-28 | |
| 2016-09-30 | 248.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 278.91K shares derived: sum of 2 quarters · filed 2017-11-07 | 278.91K shares 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | 30.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | 30.57K shares 10-Q · filed 2017-08-10 | |||
| 2016-03-31 | 0.00 shares 10-Q · filed 2017-05-12 | ||||
| 2015-12-31 | 1.04M shares 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |